Progressive Supranuclear Palsy (PSP)
Progressive Supranuclear Palsy (PSP) is a rare progressive disorder resulting from damage that occurs in brain cells over time. It causes problems with balance, speech, swallowing, movement, and vision.
DelveInsight through its newsletter offers a brief description of the disease, its causes, and its symptoms. PSP is often underdiagnosed; thus, the newsletter provides an epidemiological analysis of the disease for a transparent understanding of PSP affected population and the factors associated.
The newsletter provides an overlay of the treatment modalities in use and upcoming therapies in the PSP pipeline. The newsletter also provides market insights for 7MM (the US, EU5 (the UK, Spain, Italy, Germany, and Spain) and Japan), clinical trials ongoing, upcoming conferences, and support organizations.
Gain rich insights into Progressive Supranuclear Palsy epidemiological and market insights through our newsletter by filling up the form to your right.
Subscribe to our newsletters and directly get rich and comprehensive pharma research and market insights delivered into your inbox
Know more about What's covered:
- Indication overview
- Epidemiological trends
- Treatment approaches
- Pipeline drugs
- Key Companies
- R&D in the field
- Top conferences
- Support from International organizations
-Feature.png)